Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension. - Wikidata - wikimedia - TriplyDB

Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension.

Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension.

http://www.wikidata.org/entity/Q34694622

about

RING finger protein RNF207, a novel regulator of cardiac excitation Pleiotropic Effect of a High Resolution Mapped Blood Pressure QTL on Tumorigenesis Targeted disruption of Adamts16 gene in a rat genetic model of hypertension Mutation within the hinge region of the transcription factor Nr2f2 attenuates salt-sensitive hypertension Dr Lewis Kitchener Dahl, the Dahl rats, and the "inconvenient truth" about the genetics of hypertension The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.Use of contiguous congenic strains in analyzing compound QTLs.Increased Expression of Rififylin in A < 330 Kb Congenic Strain is Linked to Impaired Endosomal Recycling in Proximal Tubules Molecular mechanisms of experimental salt-sensitive hypertension.Construction of two novel reciprocal conplastic rat strains and characterization of cardiac mitochondria.High-resolution mapping of a novel rat blood pressure locus on chromosome 9 to a region containing the Spp2 gene and colocalization of a QTL for bone mass.Isolation and high-throughput sequencing of two closely linked epistatic hypertension susceptibility loci with a panel of bicongenic strains.Refined mapping of blood pressure quantitative trait loci using congenic strains developed from two genetically hypertensive rat models.Positional cloning of quantitative trait nucleotides for blood pressure and cardiac QT-interval by targeted CRISPR/Cas9 editing of a novel long non-coding RNA.Towards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans.A personalized, multiomics approach identifies genes involved in cardiac hypertrophy and heart failure.TARGETED DISRUPTION OF REGULATED ENDOCRINE SPECIFIC PROTEIN (RESP18) IN DAHL SS/MCW RATS AGGRAVATES SALT INDUCED HYPERTENSION AND RENAL INJURY.Postnatal Cardiovascular Consequences in the Offspring of Pregnant Rats Exposed to Smoking and Smoking Cessation Pharmacotherapies.

P2860

Q24305127-CE10A6D4-E35C-4D04-A58E-B4EB3385E445 Q28551343-F64FB752-C27C-4095-A674-95530DFFEF01 Q28567699-5DB4124A-8BDC-4C33-8A49-21860A2AD672 Q28582126-88393578-7F4D-473B-973C-C2763CA9EAEA Q28649829-18131C9F-626A-4B7B-A8F8-B90CFA013D27 Q35065245-B8A69048-4086-4995-A018-4A2CB2BDBBC7 Q35786328-51925061-840E-4C61-93BB-BCCC9D336F0D Q36147710-52F18B7E-57C0-4F33-942E-C21B6363EC9D Q36366178-AFDE9D68-9968-4490-9E67-55918BC5E9AE Q36528119-5C872FAC-D7C9-4016-B640-6487953E597B Q36965788-E647049C-A610-482B-A019-5A28BD098CA4 Q37093825-CAE0F3DD-D430-4C61-9F38-5FCD43CB0649 Q37254930-1405E986-65A6-4A09-9BCC-BED75F1CE81E Q41577877-10A963B6-DC6A-48CD-94E5-2E15F0FE15AA Q46303809-20A2C311-A82A-45AA-AFA6-07021C2955E5 Q50420738-5DDC27E5-B416-44F7-9FC6-595515120C2E Q52344668-607587FE-5357-4629-8A30-70D8E95956E0 Q54412899-D03952B4-05B6-4842-9696-DC9A26C0597B

P2860

Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension.

http://www.wikidata.org/entity/Q34694622

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Augmented rififylin is a risk ...... -QT interval and hypertension.

@ast

Augmented rififylin is a risk ...... -QT interval and hypertension.

@en

Augmented rififylin is a risk ...... -QT interval and hypertension.

@nl

type

label

Augmented rififylin is a risk ...... -QT interval and hypertension.

@ast

Augmented rififylin is a risk ...... -QT interval and hypertension.

@en

Augmented rififylin is a risk ...... -QT interval and hypertension.

@nl

prefLabel

Augmented rififylin is a risk ...... -QT interval and hypertension.

@ast

Augmented rififylin is a risk ...... -QT interval and hypertension.

@en

Augmented rififylin is a risk ...... -QT interval and hypertension.

@nl

P1433

Q34694622-5B962C0C-C313-4CB9-B3E3-3B81F3FF1A0B

P1476

Q34694622-3E4DB08E-A0ED-46AA-AF0C-8BF26DADB4CB

P2093

Q34694622-078E4D5C-EBE3-46C5-AEB4-CD04DCB5425C

Q34694622-0BA28F87-0C49-4CDD-819F-E5A019F99F20

Q34694622-1FA364C1-72DD-4825-AEC7-E6E9351C1C5B

Q34694622-359B3275-3843-475F-AC39-756966C13CFC

Q34694622-692228DB-48DF-4C73-845D-733266E94076

Q34694622-8CBB450E-391E-491A-A5AA-D90A722C6CD0

Q34694622-8FB88187-DBEB-4A13-B07A-D1583A4BDBA5

Q34694622-ACEC8A66-54B8-4FD3-8A91-0F1C64E9C152

Q34694622-D4A83219-7300-4C99-8CAD-278F175EA423

Q34694622-F87AC08A-3D97-494E-AEEB-278A57B9D922

P2860

Q34694622-0C2B3839-F7AC-4B58-85E1-D6E439633DED

Q34694622-0DE4E337-FA9C-4306-B210-711C1ECB8C33

Q34694622-2DF1F7C1-8114-4038-96FF-A44B0C11FE63

Q34694622-2F917B76-FEF9-4CA7-9DA4-82131265C834

Q34694622-32858E37-60B2-4B7F-AAC8-C7D5CA8493A1

Q34694622-428C4829-0569-400A-A32D-E0A7D7438C0C

Q34694622-48A5783A-4966-4F23-9F40-E666BC087B14

Q34694622-4992FF16-B76C-49E2-9CA6-8C798567EE18

Q34694622-4DD28DC1-30AA-4A8B-A82C-B8E7B290632B

Q34694622-505EA336-CDA9-4778-9131-C52B1E9716D0

P304

Q34694622-F4596606-3D94-48DB-9AC7-E54AE773D86D

P31

Q34694622-EC0E198C-6599-4CCC-8572-8EC2898F45FB

P356

Q34694622-C8F82CA9-F1DE-47B7-BB38-E5A5AE6E3D89

P407

Q34694622-3D6001D9-9B92-484E-976A-DE694A9CE826

P433

Q34694622-CD7E71F5-DF3A-4FAC-97A1-0B831228955F

P478

Q34694622-9175BB9E-7712-4A79-994D-A45667A88954

P577

Q34694622-1E61C592-305B-4C74-A711-55C7FD929992

P698

Q34694622-24EA39E9-3C1D-4CF8-BE10-156D8418F937

P921

Q34694622-A7EEDAA9-6EE5-4AA7-89B1-218A4C85FB67

P932

Q34694622-E5010166-425C-452A-B6D4-55FAA59C65D9

P356

HYPERTENSIONAHA.110.165803

P1433

P1476

Augmented rififylin is a risk ...... -QT interval and hypertension.

@en

P2093

Andrea Kalinoski

http://www.w3.org/2001/XMLSchema#string

Bina Joe

http://www.w3.org/2001/XMLSchema#string

Eric E Morgan

http://www.w3.org/2001/XMLSchema#string

Jian Wu

http://www.w3.org/2001/XMLSchema#string

Kathirvel Gopalakrishnan

http://www.w3.org/2001/XMLSchema#string

Lijun Liu

http://www.w3.org/2001/XMLSchema#string

Phyllis Farms

http://www.w3.org/2001/XMLSchema#string

Shane Yerga-Woolwine

http://www.w3.org/2001/XMLSchema#string

Sivarajan Kumarasamy

http://www.w3.org/2001/XMLSchema#string

Xiaochen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Over-expression of Rififylin, a new RING finger and FYVE-like domain-containing protein, inhibits recycling from the endocytic recycling compartment

CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation

MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex

Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes

A KCNE2 mutation in a patient with cardiac arrhythmia induced by auditory stimuli and serum electrolyte imbalance.

Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine

Emerging roles of ubiquitin in transcription regulation.

Common variants at ten loci modulate the QT interval duration in the QTSCD Study.

Ubiquitin and control of transcription.

Physiological mechanisms influencing cardiac repolarization and QT interval.

P304

764-771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.110.165803

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21357277

http://www.w3.org/2001/XMLSchema#string

P921

P932

3060303

http://www.w3.org/2001/XMLSchema#string